Autor(es): Rodrigues, Rui S. ; Lourenço, Diogo M. ; Paulo, Sara L ; Mateus, Joana ; Ferreira, Miguel F. ; Mouro, Francisco ; Moreira, João B. ; Ribeiro, Filipa ; Sebastião, Ana M ; Xapelli, Sara
Data: 2019
Identificador Persistente: http://hdl.handle.net/10451/49114
Origem: Repositório da Universidade de Lisboa
Assunto(s): Cannabinoids; Neural stem cells; Neurogenesis; Regeneration; Pathophysiology
With the increase of life expectancy, neurodegenerative disorders are becoming not only a health but also a social burden worldwide. However, due to the multitude of pathophysiological disease states, current treatments fail to meet the desired outcomes. Therefore, there is a need for new therapeutic strategies focusing on more integrated, personalized and effective approaches. The prospect of using neural stem cells (NSC) as regenerative therapies is very promising, however several issues still need to be addressed. In particular, the potential actions of pharmacological agents used to modulate NSC activity are highly relevant. With the ongoing discussion of cannabinoid usage for medical purposes and reports drawing attention to the effects of cannabinoids on NSC regulation, there is an enormous, and yet, uncovered potential for cannabinoids as treatment options for several neurological disorders, specifically when combined with stem cell therapy. In this manuscript, we review in detail how cannabinoids act as potent regulators of NSC biology and their potential to modulate several neurogenic features in the context of pathophysiology.
